BGI Genomics Co (SZSE:300676) Total Equity : ¥10,044 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BGI Genomics Co Total Equity?

BGI Genomics Co's total equity for the quarter that ended in Mar. 2024 was ¥10,044 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

BGI Genomics Co Total Equity Historical Data

The historical data trend for BGI Genomics Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGI Genomics Co Total Equity Chart

BGI Genomics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

4,458.05

6,025.74

9,441.27

10,221.29

10,004.02

BGI Genomics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Equity	Get a 7-Day Free Trial															10,225.09	10,065.97	10,092.74	10,004.02	10,043.52

BGI Genomics Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

BGI Genomics Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	13613.008	-	3608.988
	=	10,004

BGI Genomics Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2024 )	-	Total Liabilities(Q: Mar. 2024 )
	=	13457.043	-	3413.525
	=	10,044

BGI Genomics Co Total Equity Related Terms

Thank you for viewing the detailed overview of BGI Genomics Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BGI Genomics Co (SZSE:300676) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BGI Genomics Co Ltd (SZSE:300676) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

21 Hongan Third Street, Dong, Huada Complex Park, Yantian District, Shenzhen, CHN, 518083

Website

http://www.bgi.com

BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.

Executives

Wang Jian	Director
Liu Na	Executives
Sun Ying Jun	Director
Yin Ye	Directors, executives
Du Yu Tao	Directors, executives
Li Song Gang	Supervisors
Hu Yu Jie	Supervisors
Xu Qian	Secretary Dong
Li Zhi Ping	Executives
Chen Yi Qing	Executives
Li Wen Qi	Supervisors

BGI Genomics Co (SZSE:300676) Headlines

No Headlines